跳至主要内容
临床试验/NCT06945328
NCT06945328尚未招募不适用

Study of Patients With Drug-induced Non-variceal Upper Gastrointestinal Bleeding

Assiut University0 个研究点目标入组 100 人开始时间: 2025年5月最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
主要终点
Association between non-variceal UGIB and the use of different drugs

研究概览

简要总结

  • To study the association between non-variceal UGIB and the use of NSAIDs, VKAs, DOACs and antiplatelet therapy.
  • To compare the severity of bleeding related to specified drugs.
  • To determine risk factors associated with non-variceal UGIB.

详细描述

Upper gastrointestinal bleeding (UGIB) carries a high mortality, especially in elderly patients having co-morbidities, and the incidence of non-variceal and variceal bleeding is reported to be 3.5% and 15%, respectively.

Atrial fibrillation, deep vein thrombosis, pulmonary embolism, and other conditions require anticoagulation, non-steroidal anti-inflammatory drugs (NSAIDs) and antiplatelet therapy putting the patients at high risk of hemorrhage.

The latest American Heart Association (AHA) report on cardiovascular diseases suggests a doubling of the prevalence of atrial fibrillation by 2030 compared to 2010. The need to institute anticoagulation for this condition, both as primary and secondary prevention, will automatically increase the number of UGIB cases. An improvement in this regard has occurred with the advent of direct oral anticoagulants (DOACs) which have been shown to be non-inferior to vitamin K antagonists (VKAs).

In the event of UGIB, the Rockall score is a valid prediction score, repeatedly confirmed to assess the risk of patients with non-variceal bleeding. The management of UGIB is commonly adapted according to this score. Identifying high-risk patients who may benefit from longer hospitalization is crucial.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (aged 18 years and above) presented with signs and symptoms of UGIB (hematemesis and/or melena)

排除标准

  • Variceal bleeding
  • Age below 18 years
  • Pregnant women
  • Consent refusal

结局指标

主要结局

Association between non-variceal UGIB and the use of different drugs

时间窗: through study completion, an average of 1 year

observation the association between the incedience of Non-variceal upper Gastrointestinal Bleeding and the use of NSAIDs, VKAs, DOACs and antiplatelet therapy

次要结局

  • The severity of Non-variceal bleeding related to specified drugs.(through study completion, an average of 1 year)
  • Risk factors associated with non-variceal upper gastrointestinal bleeding(through study completion, an average of 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nada Abdelfattah Ahmed

Principal investigator

Assiut University

相似试验